Enlitic (ASX:ENL) Growth Rank : 0 (As of May. 26, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Enlitic Growth Rank?

Enlitic has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Enlitic Growth Rank Related Terms

Thank you for viewing the detailed overview of Enlitic's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Enlitic (ASX:ENL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enlitic Inc (ASX:ENL) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

3420 East Harmony Road, Suite 125, Fort Collins, CO, USA, 80528

Website

https://www.enlitic.com

Enlitic Inc is focused on artificial intelligence that enables effective administration, processing, and sharing of medical imaging data throughout the healthcare enterprise. It is also focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Enlitic provides a solid plan that addresses data inconsistencies and risk associated with moving studies containing PHI and is focused on using AI for the medical imaging layer of a real-world evidence (RWE), providing healthcare organizations with a stepwise approach to operationalizing their AI.

Enlitic (ASX:ENL) Headlines

No Headlines